Mercer Global Advisors Inc Grifols Sa Transaction History

Mercer Global Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.71 - $11.56 $12,081 - $18,114	1,567 Added 5.54%	29,868 $345,000
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $24,538 - $30,046	2,754 Added 10.78%	28,301 $259,000
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $36,578 - $47,592	5,123 Added 25.08%	25,547 $234,000
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $135,819 - $218,332	20,424 New	20,424 $150,000
Q3 2020 Dec 10, 2020	SELL	$15.4 - $20.16 $221,944 - $290,545	-14,412 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$18.24 - $21.45 $262,874 - $309,137	14,412 New	14,412 $263,000
Q4 2019 Feb 13, 2020	SELL	$19.57 - $23.52 $215,250 - $258,696	-10,999 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$19.85 - $22.76 $15,840 - $18,162	-798 Reduced 6.76%	10,999 $220,000
Q2 2019 Aug 14, 2019	SELL	$17.59 - $21.1 $2,128 - $2,553	-121 Reduced 1.02%	11,797 $249,000
Q1 2019 Apr 23, 2019	SELL	$18.01 - $20.11 $46,573 - $52,004	-2,586 Reduced 17.83%	11,918 $240,000
Q1 2019 Apr 12, 2019	BUY	$18.01 - $20.11 $261,217 - $291,675	14,504 New	14,504 $266,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.